New Drug Keeps Common Breast Cancer Under Control Longer: Study

SATURDAY, May 30, 2015 (HealthDay News) -- Adding a new drug called Ibrance (palbociclib) to standard hormone therapy helped keep a common type of breast cancer under control measurably longer than the hormone therapy alone, a new study shows.

New Research May Help Control Brown Dog Ticks

FRIDAY, May 29, 2015 (HealthDay News) -- New research may lead to more effective ways to control the brown dog tick, a species that can cause major problems for dogs and their owners.

150 People May Have Had Contact With Lassa Fever Victim: CDC

FRIDAY, May 29, 2015 (HealthDay News) -- At least 150 people may have had contact with a New Jersey man who died Monday in that state of Lassa fever, but most of them aren't at serious risk of infection, U.S. health officials reported Thursday.

FDA Warns of Complications From Facial Fillers

FRIDAY, May 29, 2015 (HealthDay News) -- Soft tissue fillers used in cosmetic procedures can accidentally be injected into blood vessels in the face and cause serious harm, the U.S. Food and Drug Administration warns.

Rapamune Approved for Rare Lung Disease

FRIDAY, May 29, 2015 (HealthDay News) -- Rapamune (sirolimus) has been approved by the U.S. Food and Drug Administration to treat a rare, progressive lung disease that mostly affects women of childbearing age.

Health Highlights: May 29, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Oil and Gas Industry Worker Death Rate Down by a Third

THURSDAY, May 28, 2015 (HealthDay News) -- Even as the oil and gas extraction industry in the United States boomed, there was a decline in the rate of worker deaths, a new federal government study shows.

Teen Drivers a Danger to Others on the Road, Report Warns

THURSDAY, May 28, 2015 (HealthDay News) -- Teen drivers are a threat to everyone on the road, a new study warns.

Two Drugs Approved for Irritable Bowel

THURSDAY, May 28, 2015 (HealthDay News) -- Two new therapies to treat irritable bowel syndrome accompanied by diarrhea (IBS-D) in adults have been approved by the U.S. Food and Drug Administration.

Average New Yorker Sits 7 Hours Each Day: Study

THURSDAY, May 28, 2015 (HealthDay News) -- They may live in the "City That Never Sleeps," but most New Yorkers still sit around a lot -- an average of seven hours every day, a new study shows.